Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis—A Ten-Year Report from the China Children Transplant Group

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 11, 2016, Pages 2104-2108

  Wang, Jianmin ^a   Luan, Zuo ^b   Jiang, Hua ^c   Fang, Jianpei ^d   Qin, Maoquan ^e   Lee, Vincent ^f   Chen, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Guangzhou Women and Children's Medical Center   (China)

^d SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Children; Mucopolysaccharidosis; Multicenter

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILDHOOD DISEASE; CHIMERA; CHINA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FOLLOW UP; HEPATOSPLENOMEGALY; HUMAN; INCIDENCE; INTELLIGENCE QUOTIENT; MALE; MUCOPOLYSACCHARIDOSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SHORT STATURE; SPEECH DISORDER; SURVIVAL RATE; UNRELATED DONORS; UPPER RESPIRATORY TRACT OBSTRUCTION; VALVULAR HEART DISEASE; CHILD; COMPLICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; MORTALITY; PRESCHOOL CHILD; PROCEDURES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING;

HLA ANTIGEN;

CHILD; CHILD, PRESCHOOL; CHINA; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INFANT; MALE; MUCOPOLYSACCHARIDOSES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

EID: 84992347210     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2016.08.015     Document Type: Article

References (18)

1. 1 Priller, J., Flugel, A., Wehner, T., et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med 7 (2001), 1356–1361.
2. 2 De Ru, M.H., Boelens, J.J., Das, A.M., et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis, 6, 2011, 55, 10.1186/1750-1172-6-55.
3. 3 Krivit, W., Peters, C., Shapiro, E.G., Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 12 (1999), 167–176.
4. 4 Hobbs, J.R., Hugh-Jones, K., Barrett, A.J., et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2 (1981), 709–712.
5. 5 Muenzer, J., Wraith, J.E., Clarke, L.A., International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123 (2009), 19–29.
6. 6 Jaap, J.B., Mieke, A., Duncan, P., et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood 121 (2013), 3981–3987.
7. 7 Turbeville, S., Nicely, H., Rizzo, J.D., et al. Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. Mol Genet Metab 102 (2011), 111–115.
8. 8 Aldenhoven, M., Jones, S.A., Bonney, D., et al. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines. Biol Blood Marrow Transplant 21 (2015), 1106–1109.
9. 9 Boelens, J.J., Wynn, R.F., O'Meara, A., et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 40 (2007), 225–233.
10. 10 Scarpa, M., Almássy, Z., Beck, M., et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis, 6, 2011, 72.
11. 11 Tomatsu, S., Yasuda, E., Patel, P., et al. Morquio A syndrome: diagnosis and current and future therapies. Pediatr Endocrinol Rev 12:suppl 1 (2014), 141–151.
12. 12 Giugliani, R., Harmatz, P., Wraith, J.E., Management guidelines for mucopolysaccharidosis VI. Pediatrics 120 (2007), 405–418.
13. 13 Aldenhoven, M., Wynn, R.F., Orchard, P.J., et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood 125 (2015), 2164–2172.
14. 14 Vlasta, F., Paola, C., Giovanna, S., et al. Natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young 19 (2009), 170–178.
15. 15 Marleen, H.L., Moyo, C.K., Ralph, J.B.S., et al. Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review. J Inherit Metab Dis 34 (2011), 657–669.
16. 16 Charles, P., Elsa, G.S., James, A., Storage Disease Collaborative Study Group. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91 (1998), 2601–2608.
17. 17 Nathalie, G., Yves, B., Isabelle, F., et al. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr 154 (2009), 733–737.
18. 18 Akemi, T., Torayuki, O., Yasuyuki, S., et al. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. Mol Genet Metab 107 (2012), 513–520.